SP-MHCI-0105-1

Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

US$112.00

In stock

Description

About Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL) - Endogenous retrovirus group K member 18 Env polyprotein; AA 485-494 for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL) - Specifications

Amount: 50 µg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in glass vial
Application(s): T-cell immunity
Condition(s)/Topic(s): Autoimmune disease
Standard Delivery Time: 2-5 days

Are you interested in your other antigen peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!

References

References for Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

References:
Read References with Antigen Peptides

Testimonials
"To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides."
Dr. Laura J Pallett, Infection and Immunity, University College London, UK

Documentation

Documentation for Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

Properties

Properties of Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Autoimmune disease
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Envelope protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: Yes

Further Information to Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

Information Values
Sequence: H-QIFEASKAHL-OH
Specifications: 10mer peptide as TFA salt
Loading...
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote